<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Little is known about the risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> among patients with <z:e sem="disease" ids="C0022104" disease_type="Disease or Syndrome" abbrv="IBS">irritable bowel syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We conducted a nationwide cohort study using data from the Danish National Registry of Patients and the Danish <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Registry from 1977 to 2008 </plain></SENT>
<SENT sid="2" pm="."><plain>We included patients with a first-time hospital contact for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e> and followed them for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We estimated the expected number of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> by applying national rates and we computed standardised incidence ratios (SIRs) by comparing the observed number of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> with the expected number </plain></SENT>
<SENT sid="4" pm="."><plain>We stratified the SIRs according to age, gender, and time of follow-up </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Among 57,851 IBS patients, we identified 407 cases of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> during a combined follow-up of 506,930 years (SIR, 1.14 (95% confidence interval (CI): 1.03-1.25) and 115 cases of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e>, corresponding to a SIR of 0.67 (95% CI: 0.52-0.85) </plain></SENT>
<SENT sid="6" pm="."><plain>In the first 3 months after an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e> diagnosis, the SIR was 8.42 (95% CI: 6.48-10.75) for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> and 4.81 (95% CI: 2.85-7.60) for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Thereafter, the SIRs declined and 4-10 years after an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e> diagnosis, the SIRs for both colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> remained below 0.95 </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: We found a decreased risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in the period 1-10 years after an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e> diagnosis </plain></SENT>
<SENT sid="9" pm="."><plain>However, in the first 3 months after an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IBS</z:e> diagnosis, the risk of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> was more than eight-fold increased and the risk of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> was five-fold increased </plain></SENT>
<SENT sid="10" pm="."><plain>These increased risks are likely to be explained by diagnostic <z:hpo ids='HP_0001289'>confusion</z:hpo> because of overlapping symptomatology </plain></SENT>
</text></document>